• Job Description

  Req#: 3021156

  Title: Postdoc

  Salary: $72,500

  Department: Neurology

  Physical work location: Hess-9-121

  Name PI or Supervisor: (include phone and email). Zhenyu Yue, Tel 212 241 8983, email zhenyu.yue@mssm.edu

  Web link to Lab: https://labs.icahn.mssm.edu/yuelab/

  Web link to Department: https://icahn.mssm.edu/about/departments/neurology

  Administrative Contact: Lidija Ivic

  Qualifications

  Educational and other Requirements for the position: MD or PhD

  Experience Required: Extensive training in basic neuroscience, molecular and cellular biology, animal models, and neurological disorder mechanism research.

  Goals/Outcomes of the Research Project: The goal is to develop the skills and independence in neurological disease research and to become successful researchers. The fellow will improve their analytic thinking, public presentation, and professional writing. The fellow is expected to publish research results in professional journals, secure funding/fellowship, teach and mentor junior researchers, and develop leadership and management skills.

  SPOC-UAW Local 4100 at Icahn School of Medicine (Post Docs), 841 - Neurology - ISM, Icahn School of Medicine

  EOE Minorities/Women/Disabled/Veterans

  The Mount Sinai Health System is an equal opportunity employer. We comply with applicable Federal civil rights laws and does not discriminate, exclude, or treat people differently on the basis of race, color, national origin, age, religion, disability, sex, sexual orientation, gender identity, or gender expression. We are passionately committed to addressing racism and its effects on our faculty, staff, students, trainees, patients, visitors, and the communities we serve. Our goal is for Mount Sinai to become an anti-racist health care and learning institution that intentionally addresses structural racism.?

  Responsibilities

  Details of Research Projects:

  1. Autophagy-lysosome dysfunctions in neurons and glial cells in the pathogenesis of neurodegenerative diseases

  We propose to elucidate the cell-type-specific autophagy-lysosome pathways, focusing on neurons and microglia, under both physiological (young and old) and pathological conditions (Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease). Employing a systematic approach, we will incorporate multiple genetic mutant lines of mice, human-induced neuron lines (hiN), quantitative proteomics, and molecular and cell biology techniques to identify autophagy cargo and receptors in neurons and microglia. Furthermore, we will investigate the distinct mechanisms responsible for the degradation of multiple disease-associated proteins such as tau, alpha-synuclein (aSyn), and huntingtin. The findings of our study hold the potential to uncover novel biomarkers and therapeutic targets for autophagy-lysosomes in the treatment of Alzheimer’s, Parkinson’s, and Huntington’s diseases, thereby paving the way for innovative therapeutic interventions.

  1. Dysfunctional AKAP11-PKA signaling underlying the pathogenic mechanism and in modeling psychiatric disease condition (schizophrenia and bipolar)

  Recent human genetic study has identified AKAP11 as a definitive causal gene for bipolar disorder and enhanced risk factor for schizophrenia. Our study demonstrated AKAP11 is an autophagy receptor that mediates selective degradation of PKA-RI complex through autophagy. Our goal is to dissect the pathogenic mechanism whereby AKAP11 deficiency contributes to the psychiatric illness by characterizing genetic animal models and induced human neuron (iNeuron) models. We will test the new therapeutic ideas by targeting AKAP11-PKA signaling and activity.

  Technical Duties:

  • Flow-cytometry
  • ELISA
  • WB
  • ELISPOT
  • qPCR
  • CyTOF data analyses
  • Mouse genetics,
  • molecular and cellular biology approaches,
  • primary neuron/glia cultures, cellular imaging (both live and fixed),
  • transcriptomics (including single-cell RNA sequencing and spatial transcriptomics),
  • proteomics, bioinformatics, and animal pathology/behavioral studies.

• About the company

  The mission of the Mount Sinai Health System is to provide compassionate patient care with seamless coordination and to advance medicine through unrivaled education, research, and outreach in the many diverse communities we serve.

Notice